MedPath

'Medroxyprogesterone acetate (MPA) in Familial Adenomatous Polyposis, a proof of principle study’

Conditions
Familial adenomatous polyposis
Registration Number
NL-OMON25407
Lead Sponsor
afdeling maag darm en leverziekten LUMC
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

1. Females > 14 years of age

2.Established FAP, confirmed by prior colonoscopy

Exclusion Criteria

1. Females before menarche

2.Prior progestin use in the past year

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in polyp burden
Secondary Outcome Measures
NameTimeMethod
Biological response in the target tissue (colon)
© Copyright 2025. All Rights Reserved by MedPath